Long-term survival in node-positive breast cancer treated by locoregional therapy alone
Author Information
Author(s): H Joensuu, L Pylkkanen, S Toikkanen
Primary Institution: Helsinki University Central Hospital
Hypothesis
The presence of axillary nodal metastases at the time of diagnosis is not a conclusive sign of disseminated breast cancer.
Conclusion
A considerable proportion of women with node-positive breast cancer treated with locoregional therapy alone can become long-term survivors.
Supporting Evidence
- 15-year survival rate corrected for intercurrent deaths was 26%.
- 30-year survival rate corrected for intercurrent deaths was 21%.
- None of the patients with pN2 disease survived for 15 years.
- Women with pTl N1 MO cancer had a 59% 15-year survival rate.
Takeaway
Some women with breast cancer that has spread to lymph nodes can live a long time even without extra treatments, showing that local treatment can sometimes work really well.
Methodology
The study reviewed clinical and autopsy records of 1172 women diagnosed with breast cancer, identifying 339 with node-positive disease treated with locoregional therapy alone, followed for at least 15 years.
Potential Biases
Potential selection bias due to the exclusion of patients who received systemic therapy and those with bilateral breast cancer.
Limitations
The study may not account for all variables affecting survival, and the data is based on historical records from a specific geographical area.
Participant Demographics
All participants were women diagnosed with unilateral node-positive breast cancer, median age at diagnosis was 56 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI, 21-31%
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website